Key result
Transcatheter aortic valve implantation in 7 high-risk patients with bicuspid aortic valve stenosis resulted in 6 survivors at one year who achieved significant functional improvement.
Why the study?
Does transcatheter aortic valve implantation (TAVI) improve outcomes in high-risk patients with severe bicuspid aortic valve stenosis?
Case Report (n=7)
No
Does transcatheter aortic valve implantation (TAVI) improve outcomes in high-risk patients with severe bicuspid aortic valve stenosis?
TAVI appears to be a feasible and relatively safe alternative for high-risk patients with severe bicuspid aortic valve stenosis, showing good 1-year survival and functional improvement.
Supports TAVI feasibility in high-risk bicuspid stenosis; hypothesis-generating and should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kosek et al. (2015) conducted a case report in Severe symptomatic bicuspid aortic valve stenosis (n=7). Transcatheter aortic valve implantation (TAVI) was evaluated on Survival and functional improvement at 1 year. Transcatheter aortic valve implantation in 7 high-risk patients with bicuspid aortic valve stenosis resulted in 6 survivors at one year who achieved significant functional improvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: